Trial Outcomes & Findings for Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation (NCT NCT00779701)
NCT ID: NCT00779701
Last Updated: 2017-03-16
Results Overview
Recruitment status
COMPLETED
Study phase
PHASE4
Target enrollment
27 participants
Primary outcome timeframe
Study duration 6 hours. Blood glucose checked at 30 minutes then every 15 minutes until within target blood glucose range then every hour.
Results posted on
2017-03-16
Participant Flow
Participant milestones
| Measure |
Insulin Infusion
All subjects placed on insulin infusion.
Insulin: Insulin infusion titrated to patients blood glucose to maintain blood glucose between 80-110mg/dL
|
|---|---|
|
Overall Study
STARTED
|
27
|
|
Overall Study
COMPLETED
|
27
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation
Baseline characteristics by cohort
| Measure |
Insulin Infusion
n=27 Participants
All subjects placed on insulin infusion.
Insulin: Insulin infusion titrated to patients blood glucose to maintain blood glucose between 80-110mg/dL
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
12 Participants
n=99 Participants
|
|
Age, Categorical
>=65 years
|
15 Participants
n=99 Participants
|
|
Sex: Female, Male
Female
|
11 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
16 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
27 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: Study duration 6 hours. Blood glucose checked at 30 minutes then every 15 minutes until within target blood glucose range then every hour.Outcome measures
| Measure |
Insulin Infusion
n=27 Participants
All subjects placed on insulin infusion.
Insulin: Insulin infusion titrated to patients blood glucose to maintain blood glucose between 80-110mg/dL
|
|---|---|
|
Time to Achieve Glycemic Control
|
225 Minutes
Standard Deviation 48.8
|
Adverse Events
Insulin Infusion
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place